Wikidata

(Q61918591)

English

Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

clinical trial

In more languages

Statements

title
Double-blind, Placebo-controlled, Randomized, Parallel-group Phase II Study in Subjects With Relapsing Forms of Multiple Sclerosis (MS) to Evaluate the Safety, Tolerability, and Effects of CDP323. (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
sponsor
UCB Pharma
0 references
country
Belgium
0 references
Canada
0 references
Finland
0 references
France
0 references
Germany
0 references
Hungary
0 references
Netherlands
0 references
Spain
0 references
Sweden
0 references
United Kingdom
0 references
start time
May 2007
0 references
end time
November 2009
0 references
number of participants
232
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61918591&oldid=2109612644"